Neuraly CEO Seulki Lee (L) and scientific co-founder Ted Dawson
March 27, 2023 07:00 AM EDTUpdated 09:26 AM
R&D

An­oth­er biotech start­up runs in­to a PhII pile­up in Parkin­son's

John Carroll

Editor & Founder

GLP-1R ag­o­nists have be­come stan­dard ther­a­pies in di­a­betes, with some proven weight loss fea­tures and a safe­ty pro­file that promis­es to bring them in­to the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times